RecruitingNCT07288710

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

A Prospective Observational Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy


Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Enrollment

300 participants

Start Date

Mar 9, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • adult patients (age ≥ 18 years)
  • American Society of Anesthesiologists (ASA) grade of III or below
  • scheduled for VATS from March to December 2023

Exclusion Criteria5

  • age \<18 years
  • inability or poor compliance to use wearable devices
  • lack of smartphone
  • incomplete digital device data during hospitalization
  • patients with lymph node or distant metastasis

Locations(1)

Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07288710


Related Trials